At 24h post-injection, CX3CR1-GFP+CD115+ monocytes were detected in the lungs and in the tumor-draining mediastinal LNs, but not in the control inguinal LNs (Figure 5C). This evidence concerns the gene CX3CR1 and neoplasm.